American Heart Journal
Volume 156, Issue 4 , Pages 674-681 , October 2008

Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines—Heart Failure Program study

  • Uptal D. Patel, MD

      Affiliations

    • Division of Nephrology, Duke University Medical Center, Durham, NC
    • Duke Clinical Research Institute, Durham, NC
    • Corresponding Author InformationReprint requests: Uptal D. Patel, MD, Duke Clinical Research Institute, DUMC Box 3646, Nephrology, Durham, NC 27710.
    • ,
  • Adrian F. Hernandez, MD, MHS

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • Division of Cardiovascular Medicine, Duke University Medical Center, Durham, NC
    • ,
  • Li Liang, PhD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • Eric D. Peterson, MD, MPH

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • Division of Cardiovascular Medicine, Duke University Medical Center, Durham, NC
    • ,
  • Kenneth A. LaBresh, MD

      Affiliations

    • MassPro, Waltham, MA
    • ,
  • Clyde W. Yancy, MD

      Affiliations

    • Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX
    • ,
  • Nancy M. Albert, RN, PhD

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • Gray Ellrodt, MD

      Affiliations

    • Berkshire Medical Center, Pittsfield, MA
    • ,
  • Gregg C. Fonarow, MD, FACC

      Affiliations

    • Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, CA

Received 23 December 2007 ,Accepted 23 May 2008.

References 

  1. Association AH. Heart disease and stroke statistics—2007 update. Dallas (Tex): American Heart Association; 2007;
  2. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292:344–350
  3. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154–e235
  4. Prevalence of chronic kidney disease and associated risk factors—United States, 1999-2004. MMWR. 2007;56:161–165
  5. Ezekowitz J, McAlister FA, Humphries KH, et al. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol. 2004;44:1587–1592
  6. Fonarow GC, Abraham WT, Albert NM, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA. 2007;297:61–70
  7. Hernandez AF, Fonarow GC, Liang L, et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007;298:1525–1532
  8. Heidenreich PA, Fonarow GC. Are registry hospitals different? A comparison of patients admitted to hospitals of a commercial heart failure registry with those from national and community cohorts. Am Heart J. 2006;152:935–939
  9. Bonow RO, Bennett S, Casey DE, et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol. 2005;46:1144–1178
  10. Fonarow GC, Abraham WT, Albert NM, et al. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Arch Intern Med. 2007;167:1493–1502
  11. Joint Commission on Accreditation of Healthcare Organizations . Specifications manual for National Hospital Quality Measures, version 2.21. Available at http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/Historical+NHQM+manuals.htm2006;Last accessed July 14, 2007
  12. Centers for Medicare and Medicaid Services . Overview of specifications for hospital compare measures. Available at http://www.cms.hhs.gov/HospitalQualityInits/downloads/HospitalOverviewOfSpecs200512.pdf2006;Last accessed July 30, 2007
  13. Centers for Medicare and Medicaid Services . The Hospital Quality Alliance (HQA) ten measure “Starter Set”. Available at http://www.cms.hhs.gov/HospitalQualityInits/downloads/HospitalStarterSet200512.pdf2005;Last accessed July 30, 2007
  14. National Kidney Foundation Kidney Disease Outcome Quality Initiative Advisory B. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis. 2002;39:S1–246
  15. Han JH, Chandra A, Mulgund J, et al. Chronic kidney disease in patients with non–ST-segment elevation acute coronary syndromes. Am J Med. 2006;119:248–254
  16. Lee DS, Tu JV, Juurlink DN, et al. Risk-Treatment Mismatch in the pharmacotherapy of heart failure. JAMA. 2005;294:1240–1247
  17. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:2635–2645
  18. Berger AK, Duval S, Manske C, et al. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease. Am Heart J. 2007;153:1064–1073
  19. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med. 1992;327:685–691
  20. McAlister FA, Ezekowitz J, Tonelli M, et al. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation. 2004;109:1004–1009
  21. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572
  22. Heywood JT, Fonarow GC, Costanzo MR, et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: A report from the ADHERE database. J Card Fail. 2007;13:422–430

 Funding/Support: This study was funded by the American Heart Association (Dallas, TX) with support from an unrestricted educational grant from GlaxoSmithKline, Inc. (Philadelphia, PA) Doctor Patel is the recipient of grant K23 DK075929-01 from the National Institutes of Diabetes and Digestive and Kidney Diseases (Bethesda, MD). Doctor Hernandez is supported by an American Heart Association Pharmaceutical Roundtable grant 0675060N. Doctor Peterson is the recipient of grant R01 AG025312-01A1 from the National Institute on Aging (Bethesda, MD). Doctor Fonarow holds the Eliot Corday Chair of Cardiovascular Medicine and Science.

 Presented in part at the American Heart Association Scientific Sessions 2006, Chicago, IL, November 12-15, 2006.

PII: S0002-8703(08)00400-6

doi: 10.1016/j.ahj.2008.05.028

American Heart Journal
Volume 156, Issue 4 , Pages 674-681 , October 2008

Article Tools

* Image Usage & Resolution